EMBO Molecular Medicine, 1757-4684

Journal

More filtering options
More filtering options

All authors

Reset
to
1 - 10 out of 14Page size: 10
  1. 2020
  3. 2019

  4. Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease

    Sebastian Palmqvist, Philip S. Insel, Erik Stomrud, Shorena Janelidze, Henrik Zetterberg, Britta Brix, Udo Eichenlaub, Jeffrey L. Dage, Xiyun Chai, Kaj Blennow, Niklas Mattsson & Oskar Hansson, 2019 Dec 1, In: EMBO Molecular Medicine. 11, 12, e11170.

    Research output: Contribution to journal › Article

  5. Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma

    Sofie Mohlin, Karin Hansson, Katarzyna Radke, Sonia Martinez, Carmen Blanco-Apiricio, Cristian Garcia-Ruiz, Charlotte Welinder, Javanshir Esfandyari, Michael O'Neill, Joaquin Pastor, Kristoffer von Stedingk & Daniel Bexell, 2019 Aug 1, In: EMBO Molecular Medicine. 11, 8, e10058.

    Research output: Contribution to journal › Article

  6. 2018

  7. Photoreceptor glucose metabolism determines normal retinal vascular growth

    Zhongjie Fu, Chatarina A. Löfqvist, Raffael Liegl, Zhongxiao Wang, Ye Sun, Yan Gong, Chi Hsiu Liu, Steven S. Meng, Samuel B. Burnim, Ivana Arellano, My T. Chouinard, Rubi Duran, Alexander Poblete, Steve S. Cho, James D. Akula, Michael Kinter, David Ley, Ingrid Hansen Pupp, Saswata Talukdar, Ann Hellström & 1 others, Lois Eh Smith, 2018 Jan, In: EMBO Molecular Medicine. 10, 1, p. 76-90

    Research output: Contribution to journal › Article

  8. Alternative oxidase-mediated respiration prevents lethal mitochondrial cardiomyopathy

    Jayasimman Rajendran, Janne Purhonen, Saara Tegelberg, Olli Pekka Smolander, Matthias Mörgelin, Jan Rozman, Valerie Gailus-Durner, Helmut Fuchs, Martin Hrabe de Angelis, Petri Auvinen, Eero Mervaala, Howard T. Jacobs, Marten Szibor, Vineta Fellman & Jukka Kallijärvi, 2018, In: EMBO Molecular Medicine. 2018, e9456.

    Research output: Contribution to journal › Article

  9. Amyloid blood biomarker detects Alzheimer's disease

    Andreas Nabers, Laura Perna, Julia Lange, Ute Mons, Jonas Schartner, Jörn Güldenhaupt, Kai Uwe Saum, Shorena Janelidze, Bernd Holleczek, Dan Rujescu, Oskar Hansson, Klaus Gerwert & Hermann Brenner, 2018, In: EMBO Molecular Medicine. 10, 5, e8763.

    Research output: Contribution to journal › Article

  10. 2017

  11. Deletion of ribosomal protein genes is a common vulnerability in human cancer, especially in concert with TP53 mutations

    Ram Ajore, David Raiser, Marie E. McConkey, Magnus Jöud, Bernd Boidol, Brenton G Mar, Gordon Saksena, David M Weinstock, Scott Armstrong, Steven R Ellis, Benjamin L. Ebert & Björn Nilsson, 2017 Apr 1, In: EMBO Molecular Medicine. 9, 4, p. 498-507 10 p.

    Research output: Contribution to journal › Article

  12. REST suppression mediates neural conversion of adult human fibroblasts via microRNA-dependent and -independent pathways

    Janelle Drouin-Ouellet, Shong Lau, Per Ludvik Brattås, Daniella Ottosson, Karolina Pircs, Daniela A Grassi, Lucy M Collins, Romina Vuono, Annika Andersson Sjöland, Gunilla Westergren-Thorsson, Caroline Graff, Lennart Minthon, Håkan Toresson, Roger A Barker, Johan Jakobsson & Malin Parmar, 2017, In: EMBO Molecular Medicine. 9, 8, p. 1117-1131

    Research output: Contribution to journal › Article

  14. 2016

  15. Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

    Niklas Mattsson, Philip S. Insel, Sebastian Palmqvist, Erik Portelius, Henrik Zetterberg, Michael Weiner, Kaj Blennow & Oskar Hansson, 2016 Oct 1, In: EMBO Molecular Medicine. 8, 10, p. 1184-1196 13 p.

    Research output: Contribution to journal › Article

Previous 1 2 Next